Yield10 Bioscience, Inc.

YTEN · NASDAQ
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Assets
Cash & Equivalents$733$1,597$1,068$2,817
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$471$526$332$545
Total Curr. Assets$1,204$2,123$1,400$3,362
Property Plant & Equip (Net)$1,729$2,016$2,201$2,363
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$264$264
Tax Assets$0$0$0$0
Other NC Assets$35$104$42$53
Total NC Assets$1,764$2,120$2,507$2,680
Other Assets$0$0$0$0
Total Assets$2,968$4,243$3,907$6,042
Liabilities
Payables$2,369$1,646$1,202$381
Short-Term Debt$996$990$669$651
Tax Payable$0$0$0$0
Deferred Revenue$1,800$1,700$0-$977
Other Curr. Liab.$647$431$418$743
Total Curr. Liab.$7,669$6,210$4,865$3,953
LT Debt$0$0$1,525$1,697
Deferred Rev, NC$450$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0-$1,525-$1,697
Total NC Liab.$1,537$1,346$1,525$1,697
Other Liabilities$0$0$0$0
Cap. Leases$1,792$2,037$1,525$2,348
Total Liabilities$9,206$7,556$6,390$5,650
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$120$119
Retained Earnings-$419,862-$416,624-$414,152-$410,886
AOCI-$262-$262-$265-$247
Other Equity$0$0$0$0
Total Equity-$6,238-$3,313-$2,483$392
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$2,968$4,243$3,907$6,042
Net Debt$263-$607$1,126-$469